Company Selected - Takeda Pharmaceutical Co. Ltd. - Dividends-and-More
| Fiscal Year is From April To March | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | View Chart |
|---|---|---|---|---|---|
| Earnings Per Share | ¥21.14 | ¥87.97 | ¥67.59 | ¥131.90 | |
| Cash Flow Per Share | ¥719.75 | ¥646.96 | ¥602.78 | ¥661.39 | |
| EBITDA Per Share | ¥726.62 | ¥771.81 | ¥720.54 | ¥760.47 | |
| Dividend Per Share | ¥197.66 | ¥198.97 | ¥189.44 | ¥191.37 | |
| Dividend Yield | 4.62% | 4.66% | 4.34% | 4.79% | |
| Net Buyback Yield | 1.62% | 1.65% | 0.8409% | 0.0322% | |
| Total Yield (Div. + Net Buyback Yield) | 6.24% | 6.31% | 5.18% | 4.82% | |
| Net Income Dividend Coverage | 0.1069x | 0.4421x | 0.3568x | 0.6892x | |
| FCFE Dividend plus Stock Repurchases Coverage | - | 0.4015x | 0.7428x | 1.75x | |
| Dividend Payout Ratio | 935.06% | 226.17% | 280.28% | 145.09% | |
| Dividend Retention Rate | - | - | - | - | |
| Number of Consecutive Periods with Dividend Payments | 62.00 | 61.00 | 60.00 | 59.00 | |
| Number of Consecutive Periods with Dividend Growth | 8.00 | 7.00 | 6.00 | 5.00 | |
| Share of Periods with Dividend Payments in % | 95.38% | 95.31% | 95.24% | 95.16% |